The investigational therapy LYT-100 (deupirfenidone) significantly slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF), outperforming the standard of care therapy Esbriet.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Columnist Sam Kirton, who has IPF, has often needed to isolate during the holidays. Here he shares some ways he's stayed connected anyhow.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Trevi Therapeutics announced that its ongoing Phase 2b clinical trial testing Haduvio (nalbuphine extended-release tablets) in people with idiopathic pulmonary fibrosis (IPF) who have chronic cough ...

Good grief! When I hear this two-word phrase, I often associate it with the cartoon character Charlie Brown. Otherwise, the words “good” and “grief” seldom seem to belong together. What do you do with ...

The first patient has been dosed in a Phase 2b clinical trial of Endeavor Biomedicines’ investigational oral therapy ENV-101 (taladegib) in people with idiopathic pulmonary fibrosis (IPF). WHISTLE-PF ...

Trong cuộc sống hàng ngày, chúng ta sử dụng rất nhiều thiết bị điện để hỗ trợ công việc, sinh hoạt. Từ chiếc quạt mát trong những ngày hè nóng bức, đến sen vòi nóng lạnh giúp chúng ta tận hưởng ...